The Times reported that investors pulled a net £9.6 billion from UK funds last year, according to data from Calastone. It was the ninth consecutive year of net outflows, and although
The Times reported that investors pulled a net £9.6 billion from UK funds last year, according to data from Calastone. It was the ninth consecutive year of net outflows, and although
London, UK – ValiRx Plc (AIM: VAL), a life science company focusing on early-stage cancer therapeutics and women’s health announces that, further to the amendment to the Letter of Intent (“LOI”)
Gold is on track for a robust weekly gain as escalating concerns over the Russia-Ukraine conflict drive demand for safe-haven assets. Currently trading at $2,704.80 an ounce, gold is up
Zak Mir takes a charting look at some of the most followed small caps on the London stock market. Today’s charts are FTSE 100, Dax, Dow, Bitcoin, Gold, Amigo, Avacta,
Zak Mir takes a charting look at some of the most followed small caps on the London stock market. Today’s charts are FTSE 100, Dax, Dow, Bitcoin, Gold, Pound/Dollar, EnergyPathways,
Update on proposed sub-license of VAL201
ImmuPharma (IMM), the specialist drug discovery and development company, announced its interim results for the six months ended 30 June 2024. On 3 June 2024. ImmuPharma divested its investment in shares
Helium One Global (HE1), the primary helium explorer in Tanzania, announced that the Company has entered into a conditional binding heads of agreement pursuant to which Helium One has agreed to
Zak Mir takes a charting look at some of the most followed small caps on the London stock market. Today’s charts are FTSE 100, Dax, Dow, Bitcoin, Gold, Bowleven, Celebrus,
Zak Mir takes a charting look at some of the most followed small caps on the London stock market. Today’s charts are FTSE 100, Dax, Dow, Bitcoin, Gold, Avacta, Altona,
Eden Research (EDEN), the AIM-quoted company focused on sustainable biopesticides, announced that it has been named ESG Company of the Year at the prestigious 2024 Small Cap Network Awards in recognition
ValiRx plc (AIM: VAL), a life sciences company focusing on early-stage cancer therapeutics and women’s health, is today pleased to provide an operational update.